NANOVIRICIDES, INC. Legal Fees
NANOVIRICIDES, INC. (NNVC) had Legal Fees of $7.46 million as of 2020-01-26, per its 10-K filed 2020-10-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LegalFees · last filed 2021-10-12
- 2020-01-26: Legal Fees $7.46M.
- 2020-01-25: Legal Fees $7.46M.
- 2019-11-07: Legal Fees $7.50M.
- 2019-02-27: Legal Fees $25.00K; Legal Fees 1 month $25.00K.
| Period end | Legal Fees | Legal Fees 1 month |
|---|---|---|
| 2020-01-26 | $7.46M 10-K · filed 2020-10-13 | |
| 2020-01-25 | $7.46M 10-K · filed 2021-10-12 | |
| 2019-11-07 | $7.50M 10-Q · filed 2020-06-22 | |
| 2019-02-27 | $25.00K 10-K · filed 2019-08-23 | $25.00K 10-K · filed 2021-10-12 |
| 2011-12-31 | $77.60K 10-K/A · filed 2013-10-08 | |
| 2011-11-30 | $77.60K 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |